| |
FEATURES
 |
 |
 |
| |
• 11TH ANNUAL PHARM EXEC 50
Once again, Pharm Exec ranks the world’s top pharmaceutical companies by prescription drug sales, R&D spend, top products, and more. This comprehensive view of the pharma business is a must-read for industry insiders. By Patrick Clinton, Marketing Director, Health and Life Sciences, Oliver Wyman |
|
|
|
|
• MEDIA SPEND TRENDS
Where is innovation taking place in pharmaceutical marketing, and how is it delivering results? This detailed account gives the lowdown on what pharma is spending on direct-to-consumer, journals, and online advertising, plus a list of the top spenders in each medium. By Oriana Schwindt, Associate Editor
• TECH TOYS
We offer a review of the hottest gadgets and the latest technologies causing a buzz in the pharma industry. From glucose monitors to smart phone applications, Pharm Exec reports on the market’s best in electronics. By George Koroneos, News & Online Editor
• DEALMAKING ROUNDTABLE
This spring, Pharm Exec sat down with a panel of bankers and industry executives to discuss what’s ahead in deals for 2010. Don’t miss all the possible linkages and prospects for acquisition.
|
|
| |
COLUMNS
• DIRECT-TO-PATIENT
Guy Mastrion, Chief Global Creative Officer of ad agency Palio, has long kept an eye on the changing landscape of DTP advertising. He’s focusing on using new strategies like augmented reality to increase patient compliance and generalized patient knowledge.
• PROFESSIONAL MARKETING
How can you get beyond claims-driven messages to emotionally resonant physician communications while maintaining the tie to the more familiar and comfortable claims-based basis for prescribing decision-making? Michael Maeby, account manager at CMI, demonstrates how to reach a doc’s heart and head, identifying different emotional message components by segment.
Bonus Distribution:
Society of Pharma Biotech Trainers
|
|
